You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 283 No. 13, April 5, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA

School-Based Scoliosis Screening

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The American Chiropractic Association (ACA) agrees with the findings of the recent article by Dr Yawn and colleagues1 on school-based scoliosis screening as they relate to severe idiopathic scoliosis. However, the ACA believes continued screening is important for school-aged children for a number of reasons.

While medical doctors often look only for genetic malformations in children, doctors of chiropractic also screen for dysfunctional joints to which the dynamic musculoskeleton—particularly the spine—must compensate.

The alarming increase in spinal problems, such as low back pain, in adolescents2 points to the need for continued screening. Screening by a doctor of chiropractic can help determine some of these risk factors, such as poor flexibility and poor posture. In addition, a doctor of chiropractic can provide educational counseling to children on proper spinal health and correct posture.

The adult epidemic of low back pain and joint disorders is another reason to support . . . [Full Text of this Article]


RELATED ARTICLE

A Population-Based Study of School Scoliosis Screening
Barbara P. Yawn, Roy A. Yawn, David Hodge, Margary Kurland, William J. Shaughnessy, Duane Ilstrup, and Steven J. Jacobsen
JAMA. 1999;282(15):1427-1432.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease
Cui et al.
J. Leukoc. Biol. 2002;72:628-635.
ABSTRACT | FULL TEXT  

Cutting Edge: The Neurotoxic Prion Peptide Fragment PrP106-126 Is a Chemotactic Agonist for the G Protein-Coupled Receptor Formyl Peptide Receptor-Like 1
Le et al.
J. Immunol. 2001;166:1448-1451.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.